Historical award
Adaptive Biotechnologies Corporation
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (15 days old).
Fiscal year 2026: data through (15 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $89,700.0
- Potential award value
- $224,250.0
- Total obligated to date
- $46,715.0
Source date: Nov 9, 2026
Recorded work
CLONOSEQ IS FOOD AND DRUG ADMINISTRATION APPROVED FOR AN IN VITRO DIAGNOSTIC TESTING SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.
Award activity
- Obligations in covered fiscal years
- $89,700.00
- Transactions in covered fiscal years
- 5
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_HT001425P0034_9700_-NONE-_-NONE-